These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 27568206)

  • 1. AKT/GSK3β Signaling in Glioblastoma.
    Majewska E; Szeliga M
    Neurochem Res; 2017 Mar; 42(3):918-924. PubMed ID: 27568206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PI3K/Akt/mTOR signaling pathway and targeted therapy for glioblastoma.
    Li X; Wu C; Chen N; Gu H; Yen A; Cao L; Wang E; Wang L
    Oncotarget; 2016 May; 7(22):33440-50. PubMed ID: 26967052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent advances in the use of PI3K inhibitors for glioblastoma multiforme: current preclinical and clinical development.
    Zhao HF; Wang J; Shao W; Wu CP; Chen ZP; To ST; Li WP
    Mol Cancer; 2017 Jun; 16(1):100. PubMed ID: 28592260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bidirectional Regulation between NDRG1 and GSK3β Controls Tumor Growth and Is Targeted by Differentiation Inducing Factor-1 in Glioblastoma.
    Ito H; Watari K; Shibata T; Miyamoto T; Murakami Y; Nakahara Y; Izumi H; Wakimoto H; Kuwano M; Abe T; Ono M
    Cancer Res; 2020 Jan; 80(2):234-248. PubMed ID: 31723002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crosstalk between PI3K/AKT/mTOR and WNT/β-Catenin signaling in GBM - Could combination therapy checkmate the collusion?
    Daisy Precilla S; Biswas I; Kuduvalli SS; Anitha TS
    Cell Signal; 2022 Jul; 95():110350. PubMed ID: 35525406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting mTOR in Glioblastoma: Rationale and Preclinical/Clinical Evidence.
    Mecca C; Giambanco I; Donato R; Arcuri C
    Dis Markers; 2018; 2018():9230479. PubMed ID: 30662577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PTP4A3 is a target for inhibition of cell proliferatin, migration and invasion through Akt/mTOR signaling pathway in glioblastoma under the regulation of miR-137.
    Wang L; Liu J; Zhong Z; Gong X; Liu W; Shi L; Li X
    Brain Res; 2016 Sep; 1646():441-450. PubMed ID: 27328425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting the PI3K/AKT/mTOR signaling pathway in glioblastoma: novel therapeutic agents and advances in understanding.
    Sami A; Karsy M
    Tumour Biol; 2013 Aug; 34(4):1991-2002. PubMed ID: 23625692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Integrated Bioinformatics Study of a Novel Niclosamide Derivative, NSC765689, a Potential
    Mokgautsi N; Wen YT; Lawal B; Khedkar H; Sumitra MR; Wu ATH; Huang HS
    Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33671112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wnt/beta-catenin and PI3K/Akt/mTOR Signaling Pathways in Glioblastoma: Two Main Targets for Drug Design: A Review.
    Shahcheraghi SH; Tchokonte-Nana V; Lotfi M; Lotfi M; Ghorbani A; Sadeghnia HR
    Curr Pharm Des; 2020; 26(15):1729-1741. PubMed ID: 32003685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nobiletin inhibits invasion via inhibiting AKT/GSK3β/β-catenin signaling pathway in Slug-expressing glioma cells.
    Zhang X; Zheng K; Li C; Zhao Y; Li H; Liu X; Long Y; Yao J
    Oncol Rep; 2017 May; 37(5):2847-2856. PubMed ID: 28339056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined inhibition of AKT/mTOR and MDM2 enhances Glioblastoma Multiforme cell apoptosis and differentiation of cancer stem cells.
    Daniele S; Costa B; Zappelli E; Da Pozzo E; Sestito S; Nesi G; Campiglia P; Marinelli L; Novellino E; Rapposelli S; Martini C
    Sci Rep; 2015 Apr; 5():9956. PubMed ID: 25898313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PKC-eta mediates glioblastoma cell proliferation through the Akt and mTOR signaling pathways.
    Aeder SE; Martin PM; Soh JW; Hussaini IM
    Oncogene; 2004 Dec; 23(56):9062-9. PubMed ID: 15489897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucose-dependent acetylation of Rictor promotes targeted cancer therapy resistance.
    Masui K; Tanaka K; Ikegami S; Villa GR; Yang H; Yong WH; Cloughesy TF; Yamagata K; Arai N; Cavenee WK; Mischel PS
    Proc Natl Acad Sci U S A; 2015 Jul; 112(30):9406-11. PubMed ID: 26170313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osthole inhibits insulin-like growth factor-1-induced epithelial to mesenchymal transition via the inhibition of PI3K/Akt signaling pathway in human brain cancer cells.
    Lin YC; Lin JC; Hung CM; Chen Y; Liu LC; Chang TC; Kao JY; Ho CT; Way TD
    J Agric Food Chem; 2014 Jun; 62(22):5061-71. PubMed ID: 24828835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin-like growth factor binding protein-2 regulates β-catenin signaling pathway in glioma cells and contributes to poor patient prognosis.
    Patil SS; Gokulnath P; Bashir M; Shwetha SD; Jaiswal J; Shastry AH; Arimappamagan A; Santosh V; Kondaiah P
    Neuro Oncol; 2016 Nov; 18(11):1487-1497. PubMed ID: 27044294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The antiproliferative effect of indomethacin-loaded lipid-core nanocapsules in glioma cells is mediated by cell cycle regulation, differentiation, and the inhibition of survival pathways.
    Bernardi A; Frozza RL; Hoppe JB; Salbego C; Pohlmann AR; Battastini AM; Guterres SS
    Int J Nanomedicine; 2013; 8():711-28. PubMed ID: 23440594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of sonic hedgehog signaling enhances cell migration and invasion by induction of matrix metalloproteinase-2 and -9 via the phosphoinositide-3 kinase/AKT signaling pathway in glioblastoma.
    Chang L; Zhao D; Liu HB; Wang QS; Zhang P; Li CL; Du WZ; Wang HJ; Liu X; Zhang ZR; Jiang CL
    Mol Med Rep; 2015 Nov; 12(5):6702-10. PubMed ID: 26299938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Receptor tyrosine kinase-Ras-PI 3 kinase-Akt signaling network in glioblastoma multiforme.
    Tuncel G; Kalkan R
    Med Oncol; 2018 Aug; 35(9):122. PubMed ID: 30078108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GSK3β Controls mTOR and Prosurvival Signaling in Neurons.
    Urbanska M; Gozdz A; Macias M; Cymerman IA; Liszewska E; Kondratiuk I; Devijver H; Lechat B; Van Leuven F; Jaworski J
    Mol Neurobiol; 2018 Jul; 55(7):6050-6062. PubMed ID: 29143288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.